These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 17850976)

  • 21. Aromatase inhibitors and breast cancer.
    Miller WR
    Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early recurrence risk: aromatase inhibitors versus tamoxifen.
    Bria E; Carlini P; Cuppone F; Vaccaro V; Milella M; Cognetti F
    Expert Rev Anticancer Ther; 2010 Aug; 10(8):1239-53. PubMed ID: 20735310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant endocrine therapy for early breast cancer.
    Andreetta C; Smith I
    Cancer Lett; 2007 Jun; 251(1):17-27. PubMed ID: 17150303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Start strong or switch? Adjuvant endocrine strategies for postmenopausal women with hormone-sensitive breast cancer.
    Tusquets Trías de Bes I; Tormo SS; Mestres JA
    Biomed Pharmacother; 2009 Jan; 63(1):1-10. PubMed ID: 18539426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the BIG results: the Breast International Group 1-98 trial analyses.
    Doughty JC
    Breast; 2008 Jan; 17 Suppl 1():S9-S14. PubMed ID: 18279765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of aromatase inhibitors in adjuvant therapy for early breast cancer.
    Jonat W; Hilpert F; Maass N
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():32-8. PubMed ID: 16273366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Towards optimal endocrine therapy for hormone-sensitive breast cancer: initial versus sequential adjuvant aromatase inhibition.
    Spicer J; Ellis P
    Cancer Lett; 2007 Apr; 248(2):165-74. PubMed ID: 16919870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of the development of letrozole and its use in advanced breast cancer and in the neoadjuvant setting.
    Bhatnagar AS
    Breast; 2006 Feb; 15 Suppl 1():S3-13. PubMed ID: 16500235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond tamoxifen: extended and late extended endocrine therapy in postmenopausal early breast cancer.
    Dodwell D; Williamson D
    Cancer Treat Rev; 2008 Apr; 34(2):137-44. PubMed ID: 18006236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal treatment strategies in hormone-responsive early breast cancer: the role of aromatase inhibitors.
    Untch M; Jackisch C
    Onkologie; 2007 Feb; 30(1-2):55-64. PubMed ID: 17264527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimising adjuvant endocrine treatment of breast cancer with aromatase inhibitors.
    Fentiman IS
    Int J Clin Pract; 2006 Jun; 60(6):689-93. PubMed ID: 16805754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant aromatase inhibitor therapy: outcomes and safety.
    Janni W; Hepp P
    Cancer Treat Rev; 2010 May; 36(3):249-61. PubMed ID: 20133065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evolving role of letrozole in the adjuvant setting: first results from the large, phase III, randomized trial BIG 1-98.
    Monnier A
    Breast; 2006 Feb; 15 Suppl 1():S21-9. PubMed ID: 16500237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are all aromatase inhibitors alike?
    Blackwell KL
    Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():35-43. PubMed ID: 19101793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical differences among the aromatase inhibitors.
    Ligibel JA; Winer EP
    Clin Cancer Res; 2003 Jan; 9(1 Pt 2):473S-9S. PubMed ID: 12538503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant endocrine therapy for early breast cancer: the story so far.
    Gradishar WJ
    Cancer Invest; 2010 May; 28(4):433-42. PubMed ID: 20307199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extending the benefits of adjuvant therapy in early HR+ breast cancer.
    Goss PE
    Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():45-52. PubMed ID: 18785006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in adjuvant endocrine therapy for postmenopausal women.
    Lin NU; Winer EP
    J Clin Oncol; 2008 Feb; 26(5):798-805. PubMed ID: 18258989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant trials: Aromatase inhibitors in early breast cancer--are they alike?
    Monnier A
    Cancer Treat Rev; 2006 Nov; 32(7):532-40. PubMed ID: 16978789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A woman's heart: the impact of adjuvant endocrine therapy on cardiovascular health.
    Ewer MS; Glück S
    Cancer; 2009 May; 115(9):1813-26. PubMed ID: 19235248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.